The largest database of trusted experimental protocols

Anti il 4 antibody 11b11

Manufactured by BioXCell
Sourced in United States

The Anti-IL-4 antibody (11B11) is a lab equipment product that functions as a neutralizing antibody against interleukin-4 (IL-4). It is a widely used tool in immunological research.

Automatically generated - may contain errors

2 protocols using anti il 4 antibody 11b11

1

Adoptive Transfer of Specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based on a previously reported protocol (14 (link)), a mixture of 1.5 µg mouse IL-4 (Peprotech, Princeton, NJ, USA) and 50 µg anti-IL-4 antibody (11B11; Bio X Cell, West Lebanon, NH, USA) was intraperitoneally injected into mice daily. After 7 days of treatment, lymphoid organs were analyzed. For the adoptive transfer, donor CD8 T cells were isolated from CD45.1 + B6 mouse splenocytes using anti-CD8 microbeads and magnetic sorting (MACS; Miltenyi Biotec, Auburn, CA, USA). Next, these CD8 T cells were sorted into CD44lowCXCR3 - and CD44hiCXCR3 + populations using a FACSAria (BD Bioscience, San Jose, CA, USA) and then labeled with Cell Trace Violet (CTV, Life Technologies, Waltham, MA, USA) for tracing. Each recipient B6 mouse received 3×106 sorted cells via lateral tail vein injection, followed by IL-4C treatment one day later.
+ Open protocol
+ Expand
2

Naive CD4+ T Cell Isolation and Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were obtained from pooled spleen and peripheral lymph nodes as previously described (18 (link)). Briefly, cells were purified by nylon wool and percoll density gradient separation. CD4 T cells were isolated by positive CD4 MACS selection (Miltenyi). Resulting CD4 cells routinely expressed a characteristic naive phenotype (small size, CD62Lhi, CD44lo and CD25lo) >97% TcR+. TH1-polarized effectors were generated in vitro as described (20 (link)). Briefly, naïve Il2−/− CD4 T cells were cultured with an equal number of irradiated APC (2x105 per mL) in the presence of exogenous IL-2 (20 ng per mL), 2 ng per mL IL-12 (Peprotech), 10 μg per mL anti-IL-4 antibody (11B11; Bioxcell), and 5 μM OVAII peptide. In vitro-primed memory cells were obtained by thoroughly washing effector cultures at 4 days and re-culturing the cells in fresh media for at least 3 days in the absence of Ag and exogenous cytokines. Live cells were isolated by Lympholyte separation (Cedarlane). All donor CD4 T cells were adoptively transferred in 200 μl phosphate buffered saline (PBS) by intravenous (i.v.) injection. A number of donor cells previously determined to be detectable at the memory phase, 2 x 106, was transferred. Donor cell injection and viral infection occurred on the same day.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!